Dysuria with Burning During Ejaculation: Diagnosis and Treatment
The most likely diagnosis is urethritis caused by Chlamydia trachomatis or Neisseria gonorrhoeae, and you should treat empirically with ceftriaxone 1000 mg IM/IV plus doxycycline 100 mg twice daily for 7 days while awaiting confirmatory testing. 1
Diagnostic Approach
Essential History and Physical Examination
- Document the character and timing of symptoms: burning specifically during ejaculation points to urethral inflammation, while dysuria alone suggests broader urinary tract involvement 1, 2
- Assess for urethral discharge: mucoid or purulent discharge is present in many cases of urethritis, though asymptomatic infections are common 1
- Sexual history is critical: recent unprotected sexual contact, number of partners, and partner symptoms help identify sexually transmitted infection risk 1
- Age matters for pathogen prediction: in men under 35 years, C. trachomatis predominates; in men over 35 years, coliform bacteria are more common 3
Required Laboratory Testing
- Urinalysis and urine culture to document pyuria (≥5 polymorphonuclear leukocytes per oil immersion field on urethral swab) and rule out bacterial cystitis 1
- Nucleic acid amplification test (NAAT) for N. gonorrhoeae and C. trachomatis using first-void urine or urethral swab—this is the gold standard for diagnosis 1, 2
- If initial testing is negative but symptoms persist, test for Mycoplasma genitalium, which causes 20-40% of nongonococcal urethritis cases 1, 2
- Gram stain of urethral discharge can provide immediate information: intracellular gram-negative diplococci confirm gonorrhea 1
Treatment Algorithm
Empiric Treatment (Before Test Results)
When diagnostic tools are unavailable or while awaiting results, treat for both gonorrhea and chlamydia 1:
This dual therapy is essential because co-infection rates are high and undertreating gonorrhea risks antibiotic resistance 1.
Targeted Treatment (After Test Results)
- If C. trachomatis confirmed: doxycycline 100 mg twice daily for 7 days (or azithromycin 1 g single dose if compliance is a concern) 1
- If N. gonorrhoeae confirmed: ceftriaxone 1000 mg IM/IV plus doxycycline to cover potential chlamydial co-infection 1
- If both tests negative but symptoms persist: consider empiric treatment for Mycoplasma genitalium or Ureaplasma urealyticum 1, 2
Partner Management
- All sexual partners within the past 60 days must be treated with the same regimen, even if asymptomatic 1
- Advise strict pelvic rest (no sexual activity) until both patient and partners complete treatment and symptoms resolve 1
Critical Pitfalls to Avoid
Do Not Miss Complicated Urethritis
- Severe infection with systemic symptoms (fever, chills, malaise) may require parenteral therapy with IV ceftriaxone 1
- Persistent symptoms after appropriate treatment warrant re-evaluation for treatment failure, reinfection, or alternative diagnoses like chronic prostatitis 1
Distinguish from Chronic Prostatitis/Chronic Pelvic Pain Syndrome
- Men with pain in the perineum, suprapubic region, or tip of penis exacerbated by ejaculation may have chronic prostatitis (NIH Type III) rather than simple urethritis 1
- The Meares-Stamey 4-glass test can differentiate chronic bacterial prostatitis from urethritis in refractory cases 1
- Treatment overlap exists: some men with chronic prostatitis respond to urethritis-directed therapy, so empiric treatment for STIs is reasonable before pursuing prostatitis-specific management 1
Do Not Overlook Non-Infectious Causes
- Interstitial cystitis/bladder pain syndrome presents with dysuria and pelvic pain but requires ≥6 weeks of symptoms and negative urine cultures 1
- Trauma or chemical irritation from lubricants, spermicides, or vigorous sexual activity can mimic infectious urethritis 2, 4
Follow-Up Requirements
- Test-of-cure is not routinely needed for uncomplicated chlamydial or gonococcal urethritis if symptoms resolve 1
- Re-test in 3 months to detect reinfection, which is common due to untreated partners 1
- If symptoms persist beyond 7 days of appropriate treatment, perform repeat NAAT and consider M. genitalium testing or referral for cystoscopy to rule out structural abnormalities 1, 2